BioXcel Therapeutics, Inc. Long-term Purchase Commitment, Amount
BioXcel Therapeutics, Inc. (BTAI) had Long-term Purchase Commitment, Amount of $1.00 million as of 2024-07-11, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LongTermPurchaseCommitmentAmount · last filed 2026-08-13
- 2024-07-11: Long-term Purchase Commitment, Amount $1.00M.
- 2022-04-30: Long-term Purchase Commitment, Amount 1 month $10.00M.
| Period end | Long-term Purchase Commitment, Amount | Long-term Purchase Commitment, Amount 1 month |
|---|---|---|
| 2024-07-11 | $1.00M 10-Q · filed 2026-08-13 | |
| 2022-04-30 | $10.00M 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |